亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors

化学 吲哚试验 立体化学 黄嘌呤氧化酶 别嘌呤醇 药效团 效力 部分 IC50型 酰胺 非布索坦 高尿酸血症 体外 生物化学 尿酸 病理 医学
作者
Bing Zhang,Yulin Duan,Yuwei Yang,Qing Mao,Fengwei Lin,Jun Gao,Xiwen Dai,Peng Zhang,Qiuhua Li,Jinxin Li,Ronghua Dai,Shaojie Wang
出处
期刊:European journal of medicinal chemistry [Elsevier BV]
卷期号:227: 113928-113928 被引量:24
标识
DOI:10.1016/j.ejmech.2021.113928
摘要

Xanthine oxidase (XO) has been an important target for the treatment of hyperuricemia and gout. The analysis of potential interactions of pyrimidinone and 3-cyano indole pharmacophores present in the corresponding reported XO inhibitors with parts of the XO active pocket indicated that they both can be used as effective fragments for the fragment-based design of nonpurine XO inhibitors. In this paper, we adopted the fragment-based drug design strategy to link the two fragments with an amide bond to design the type 1 compounds 13a-13w,14c, 14d, 14f, 14g, 14j, 14k, and 15g. Compound 13g displayed an evident XO inhibitory potency (IC50 = 0.16 μM), which was 52.3-fold higher than that of allopurinol (IC50 = 8.37 μM). For comparison, type 2 compounds 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles (25c-25g) were also designed by linking the two fragments with a single bond directly. The results showed that compound 25c from the latter series displayed the best inhibitory potency (IC50 = 0.085 μM), and it was 98.5-fold stronger than that of allopurinol (IC50 = 8.37 μM). These results suggested that amide and single bonds were applicable for linking the two fragments together to obtain potent nonpurine XO inhibitors. The structure-activity relationship results revealed that hydrophobic groups at N-atom of the indole moiety were indispensable for the improvement of the inhibitory potency in vitro against XO. In addition, enzyme kinetics studies suggested that compounds 13g and 25c, as the most promising XO inhibitors for the two types of target compounds, acted as mixed-type inhibitors for XO. Moreover, molecular modeling studies suggested that the pyrimidinone and indole moieties of the target compounds could interact well with key amino acid residues in the active pocket of XO. Furthermore, in vivo hypouricemic effect demonstrated that compounds 13g and 25c could effectively reduce serum uric acid levels at an oral dose of 10 mg/kg. Therefore, compounds 13g and 25c could be potential and efficacious agents for the treatment of hyperuricemia and gout.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xiao涂完成签到,获得积分10
16秒前
25秒前
闫雪发布了新的文献求助10
31秒前
打打应助闫雪采纳,获得10
42秒前
吗喽完成签到,获得积分10
46秒前
某某某完成签到,获得积分10
50秒前
1分钟前
爱吃橙子完成签到 ,获得积分10
1分钟前
丰富莹芝发布了新的文献求助10
1分钟前
思源应助丰富莹芝采纳,获得10
1分钟前
Akitten发布了新的文献求助10
1分钟前
qqq完成签到,获得积分10
1分钟前
1分钟前
小博发布了新的文献求助10
2分钟前
童大大完成签到,获得积分20
2分钟前
小博完成签到,获得积分10
2分钟前
CodeCraft应助糯糯采纳,获得10
3分钟前
汉堡包应助Plum22采纳,获得10
3分钟前
岁岁完成签到 ,获得积分10
4分钟前
4分钟前
Plum22发布了新的文献求助10
4分钟前
4分钟前
充电宝应助科研通管家采纳,获得10
4分钟前
cherlie应助Plum22采纳,获得20
5分钟前
5分钟前
5分钟前
5分钟前
6分钟前
6分钟前
6分钟前
6分钟前
丰富莹芝发布了新的文献求助10
6分钟前
6分钟前
糯糯发布了新的文献求助10
6分钟前
所所应助科研通管家采纳,获得10
6分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
喜悦幻灵完成签到 ,获得积分10
6分钟前
6分钟前
热心易绿完成签到 ,获得积分10
6分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990148
求助须知:如何正确求助?哪些是违规求助? 3532119
关于积分的说明 11256456
捐赠科研通 3271016
什么是DOI,文献DOI怎么找? 1805171
邀请新用户注册赠送积分活动 882288
科研通“疑难数据库(出版商)”最低求助积分说明 809228